Title of article
Androgen Deprivation Therapy and Cardiovascular Risk
Author/Authors
Mourmouris, Panagiotis Department of Urology - School of Medicine - University of Athens - Sismanoglio General Hospital - Athens, Greece , Efstathiou, Eleni Department of Clinical Therapeutics / Oncology - School of Medicine - University of Athens - Alexandra Hospital - Athens, Greece , Papatsoris, Athanasios Department of Urology - School of Medicine - University of Athens - Sismanoglio General Hospital - Athens, Greece
Pages
2
From page
653
To page
654
Abstract
Androgen deprivation therapy (ADT) is an established
therapy for metastatic prostate cancer (PC) and some
cases of locally advanced and/or localized PC (1). However,
concerns have been raised about the cardiovascular
side effects of ADT and their impact on the survival
of elderly patients with PC (1). Several studies have demonstrated
an increased incidence of coronary heart disease,
heart failure and acute myocardial infarction in
patients on ADT
Keywords
Androgen Antagonists , Androgens , Prostatic Neoplasms , Cardiovascular system
Journal title
Astroparticle Physics
Serial Year
2013
Record number
2433713
Link To Document